The pharmaceutical MMJ market is quickly becoming an enormous opportunity and investors serious about diversifying their sector holdings must own a piece of the pharma side ahead of the ever-increasing... read more →
Real Interest in Psychedelics Therapy for Mental Health Began When Psychiatrist Humphrey Osmond Started Experimenting with Mescaline in the Early 1950s Osmond's Subject at the Time Was Aldous Huxley, a... read more →
Efforts to Legalize Psilocybin Just Took a Huge Step Forward Because of an Initiative on the Ballot for Oregon Voters to Consider This November—Oregon Measure 109, the Psilocybin Program Initiative... read more →
Any New Drug Therapy That Can Be Manufactured and Sold in the United States Has to Have the Approval of the U.S. FDA. That’s the Deal. Without That Approval, Which... read more →
Psychedelics Gained Popularity as a Recreational Substance Once LSD Slipped Out of Labs in the Mid to Late 1960s Where Researchers Had Been Experimenting with it Since its Discovery by... read more →
After Getting Off to a Good Start as a Psychotherapeutic Tool By the Middle of the Last Century, It Looked Like Psychedelics Would Become Part of the Medical Mainstream Then... read more →
Welcome to the Cannabis Countdown. In this week’s rendition, we’ll recap and countdown the top 10 Marijuana and Psychedelics industry news stories for the week of March 23rd – 29th, 2020.... read more →
Welcome to the Cannabis Countdown. In this week’s rendition, we’ll recap and countdown the top 10 Marijuana Industry News stories for the week of March 2nd - 8th, 2020. Without further... read more →
One Harvard Economist Says the U.S. Government Loses up to $20 Billion a Year By Keeping Cannabis Illegal But Some Believe the Federal Government Makes Up For Prohibition Costs and... read more →
State Marijuana Laws and the Federal Government's Out-of-Date Policy Are Still Very Far Apart Washington DC Lawmakers Push the Trump Administration for Greater Cannabis Research Freedoms As of today in... read more →
